InnovAge (INNV) vs Privia Health Group (PRVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
InnovAge (INNV) has outperformed Privia Health Group (PRVA) over the past year, gaining 74.5% versus a gain of 5.5%. Over five years, INNV leads with a +20.4% price change compared with +5.7% for PRVA. Privia Health Group is the larger company by market cap ($3.20 billion vs $1.25 billion), about 2.6 times the size.
On valuation, InnovAge trades at a lower forward P/E (18.3x vs 23.1x for Privia Health Group). Privia Health Group converts more of its revenue into profit, with a net margin of 1.1% versus -0.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INNV | PRVA |
|---|---|---|
| Share price | $9.16 | $25.05 |
| Market cap | $1.25B | $3.20B |
| 1-day change | +2.81% | +1.46% |
| YTD return | +76.49% | +5.65% |
| 1-year return | +74.48% | +5.52% |
| 5-year return | +20.37% | +5.65% |
| P/E ratio (TTM) | 152.67 | 96.35 |
| Forward P/E | 18.32 | 23.08 |
| EPS (TTM) | $0.06 | $0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $989.71M | $2.12B |
| Revenue growth (YoY) | +15.93% | +22.26% |
| Net income (latest FY) | $-2.54M | $22.92M |
| Gross margin | 23.01% | — |
| Operating margin | 0.26% | 1.61% |
| Net margin | -0.26% | 1.08% |
| 52-week high | $12.64 | $28.82 |
| 52-week low | $4.70 | $18.92 |
| Distance from 52-week high | -27.53% | -13.08% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +31.00% | +25.15% |
| Average volume | 595.71K | 1.33M |
| Shares outstanding | 136.46M | 127.77M |
| Employees | 2,500 | 1,226 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Privia Health Group is about 2.6 times larger than InnovAge by market value ($3.20B vs $1.25B).
- INNV has outperformed PRVA by 69.0 percentage points over the past year.
- InnovAge trades at a higher earnings multiple (152.7x vs 96.3x trailing P/E).
- Privia Health Group grew revenue faster in its latest fiscal year (+22.26% vs +15.93%).
About InnovAge
INNV stock →InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors.
Health Care · Medical/Nursing Services · 2,500 employees
About Privia Health Group
PRVA stock →Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
Health Care · Medical/Nursing Services · 1,226 employees
INNV vs PRVA FAQ
Which is bigger, InnovAge or Privia Health Group?
Privia Health Group (PRVA) is larger, with a market capitalization of $3.20B compared with $1.25B for InnovAge (INNV).
Which stock has performed better over the past year, INNV or PRVA?
INNV returned +74.48% over the past 12 months, compared with +5.52% for PRVA (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, INNV or PRVA?
PRVA has the lower trailing P/E at 96.3, versus 152.7 for INNV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are InnovAge and Privia Health Group in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.